Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash & Current Investments (2019 - 2025)

Immunocore Holdings (IMCR) has disclosed Cash & Current Investments for 7 consecutive years, with $864.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 5.34% to $864.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $864.2 million through Dec 2025, up 5.34% year-over-year, with the annual reading at $864.2 million for FY2025, 5.34% up from the prior year.
  • Cash & Current Investments hit $864.2 million in Q4 2025 for Immunocore Holdings, down from $892.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $901.3 million in Q3 2024 to a low of $320.7 million in Q4 2021.
  • Historically, Cash & Current Investments has averaged $731.2 million across 5 years, with a median of $837.0 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 87.22% in 2021 and later decreased 0.99% in 2025.
  • Year by year, Cash & Current Investments stood at $320.7 million in 2021, then rose by 21.63% to $390.0 million in 2022, then increased by 13.48% to $442.6 million in 2023, then surged by 85.34% to $820.4 million in 2024, then grew by 5.34% to $864.2 million in 2025.
  • Business Quant data shows Cash & Current Investments for IMCR at $864.2 million in Q4 2025, $892.4 million in Q3 2025, and $882.8 million in Q2 2025.